S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
NASDAQ:STRM

Streamline Health Solutions (STRM) Stock Forecast, Price & News

$1.21
-0.04 (-3.20%)
(As of 05/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.19
$1.25
50-Day Range
$1.21
$1.83
52-Week Range
$1.17
$2.29
Volume
41,692 shs
Average Volume
32,904 shs
Market Capitalization
$58.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.77
30 days | 90 days | 365 days | Advanced Chart
Receive STRM News and Ratings via Email

Sign-up to receive the latest news and ratings for Streamline Health Solutions and its competitors with MarketBeat's FREE daily newsletter.

Streamline Health Solutions logo

About Streamline Health Solutions

Streamline Health Solutions, Inc. provides health information technology solutions and associated services for hospitals and health systems in the United States and Canada. It provides computer software-based solutions and auditing services, which captures, aggregates, and translates structured and unstructured data to deliver predictive insights. The company also offers coding and clinical documentation improvement (CDI) solutions, which includes integrated cloud-based software suite, CDI, and abstracting and physician query; and eValuator, a cloud-based pre-bill coding analysis platform. In addition, it provides financial management solutions, including accounts receivable management, denials management, claims processing, spend management, and audit management; patient care solutions; and custom integration services for CDI/abstracting, training, and audit services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Computer integrated systems design
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:STRM
Fax
N/A
Employees
66
Year Founded
N/A

Sales & Book Value

Annual Sales
$17.38 million
Book Value
$0.72 per share

Profitability

Net Income
$-6.54 million
Pretax Margin
-39.17%

Debt

Price-To-Earnings

Miscellaneous

Free Float
34,953,000
Market Cap
$58.20 million
Optionable
Not Optionable

Company Calendar

Last Earnings
4/27/2022
Today
5/19/2022
Next Earnings (Estimated)
6/14/2022
Fiscal Year End
1/31/2023

MarketRank

Overall MarketRank

1.38 out of 5 stars

Medical Sector

1098th out of 1,425 stocks

Computer Integrated Systems Design Industry

40th out of 50 stocks

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.0 5 -4 -3 -2 -1 -













Streamline Health Solutions (NASDAQ:STRM) Frequently Asked Questions

Is Streamline Health Solutions a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Streamline Health Solutions in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Streamline Health Solutions stock.
View analyst ratings for Streamline Health Solutions
or view top-rated stocks.

When is Streamline Health Solutions' next earnings date?

Streamline Health Solutions is scheduled to release its next quarterly earnings announcement on Tuesday, June 14th 2022.
View our earnings forecast for Streamline Health Solutions
.

How were Streamline Health Solutions' earnings last quarter?

Streamline Health Solutions, Inc. (NASDAQ:STRM) announced its earnings results on Wednesday, April, 27th. The company reported ($0.06) earnings per share for the quarter, meeting the consensus estimate of ($0.06). Streamline Health Solutions had a negative net margin of 37.64% and a negative trailing twelve-month return on equity of 21.43%. During the same period in the prior year, the business earned ($0.05) EPS.
View Streamline Health Solutions' earnings history
.

What guidance has Streamline Health Solutions issued on next quarter's earnings?

Streamline Health Solutions updated its FY 2021 earnings guidance on Thursday, March, 24th. The company provided EPS guidance of for the period. The company issued revenue guidance of $16.80 million-$17.40 million, compared to the consensus revenue estimate of $16.49 million.

Who are Streamline Health Solutions' key executives?
Streamline Health Solutions' management team includes the following people:
  • Mr. Wyche T. Green III, Pres, CEO & Chairman (Age 50, Pay $485.7k)
  • Mr. Thomas J. Gibson, Sr. VP, CFO & Principal Accounting Officer (Age 58, Pay $329.36k)
  • Mr. Randolph W. Salisbury, Sr. VP of Investor Relations & Chief Marketing and Sales Officer (Age 68, Pay $436.15k)
  • Jacob Goldberger, Director of Investor Relations and FP&A
  • Wendy Lucio, Chief People Officer
  • Mr. Ben Stilwill, Pres & CEO of eValuator Solutions
  • Lance Seach, Sr. VP of Bus. Devel.
  • Ms. Amy Sebero, Chief Growth Officer of eValuator Solutions
  • Jawad Shaikh, Pres & CEO of Avelead
  • Mr. Donald E. Vick Jr., Director of Sales & Operations Analytics (Age 58)
What is David Sides' approval rating as Streamline Health Solutions' CEO?

31 employees have rated Streamline Health Solutions CEO David Sides on Glassdoor.com. David Sides has an approval rating of 82% among Streamline Health Solutions' employees.

What other stocks do shareholders of Streamline Health Solutions own?
What is Streamline Health Solutions' stock symbol?

Streamline Health Solutions trades on the NASDAQ under the ticker symbol "STRM."

Who are Streamline Health Solutions' major shareholders?

Streamline Health Solutions' stock is owned by a variety of retail and institutional investors. Top institutional investors include Perkins Capital Management Inc. (3.48%), Vanguard Group Inc. (3.12%), Nicholas Hoffman & Company LLC. (0.38%), HighTower Advisors LLC (0.20%) and Concourse Financial Group Securities Inc. (0.00%). Company insiders that own Streamline Health Solutions stock include Global Healthcare Fun Tamarack and Kenan Lucas.
View institutional ownership trends for Streamline Health Solutions
.

Which major investors are selling Streamline Health Solutions stock?

STRM stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc..
View insider buying and selling activity for Streamline Health Solutions
or view top insider-selling stocks.

Which major investors are buying Streamline Health Solutions stock?

STRM stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Nicholas Hoffman & Company LLC., and HighTower Advisors LLC. Company insiders that have bought Streamline Health Solutions stock in the last two years include Global Healthcare Fun Tamarack, and Kenan Lucas.
View insider buying and selling activity for Streamline Health Solutions
or or view top insider-buying stocks.

How do I buy shares of Streamline Health Solutions?

Shares of STRM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Streamline Health Solutions' stock price today?

One share of STRM stock can currently be purchased for approximately $1.21.

How much money does Streamline Health Solutions make?

Streamline Health Solutions has a market capitalization of $58.20 million and generates $17.38 million in revenue each year. The company earns $-6.54 million in net income (profit) each year or ($0.16) on an earnings per share basis.

How many employees does Streamline Health Solutions have?

Streamline Health Solutions employs 66 workers across the globe.

What is Streamline Health Solutions' official website?

The official website for Streamline Health Solutions is www.streamlinehealth.net.

How can I contact Streamline Health Solutions?

Streamline Health Solutions' mailing address is 11800 AMBER PARK DRIVE - SUITE 125, ALPHARETTA GA, 30009. The company can be reached via phone at (888) 997-8732 or via email at [email protected].

This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.